US Stock MarketDetailed Quotes

OCUP Ocuphire Pharma

Watchlist

1.299
-0.011-0.81%

Trading Aug 26 12:35 ET

34.04MMarket Cap-2406P/E (TTM)

Ocuphire Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

3.54%41.41M

20.91%47.17M

18.35%50.52M

203.53%42.36M

133.22%40M

101.28%39.01M

72.44%42.68M

-38.34%13.96M

-Cash and cash equivalents

3.58%41.41M

20.96%47.16M

18.45%50.5M

205.67%42.35M

134.81%39.98M

102.58%38.99M

73.78%42.63M

-37.73%13.86M

-Short-term investments

-77.27%5K

-69.39%15K

-89.11%11K

-82.54%22K

-83.70%22K

-77.63%49K

-73.63%101K

Receivables

-15.53%2.31M

-41.18%3.12M

-51.90%2.33M

--11.34M

--2.73M

--5.3M

--4.85M

----

-Accounts receivable

905.93%1.36M

-32.11%1.92M

-28.66%926K

--10.13M

--135K

--2.83M

--1.3M

----

-Other receivables

-63.47%948K

-51.60%1.19M

-60.39%1.41M

--1.21M

--2.6M

--2.47M

--3.55M

----

Prepaid assets

49.49%1.03M

45.64%1.47M

-27.39%997K

-20.40%433K

-3.10%687K

-4.90%1.01M

10.46%1.37M

5.84%544K

Other current assets

93.33%87K

14.10%89K

27.50%102K

-16.39%51K

45.16%45K

136.36%78K

12.68%80K

32.61%61K

Total current assets

3.16%44.83M

14.20%51.84M

10.13%53.95M

272.14%54.19M

142.92%43.46M

121.72%45.4M

87.92%48.99M

-37.22%14.56M

Non current assets

Net PPE

--0

-57.14%3K

-50.00%4K

-44.44%5K

-40.00%6K

-36.36%7K

-Gross PPE

0.00%25K

-Accumulated depreciation

-19.05%-25K

-25.00%-25K

-31.58%-25K

-22.22%-22K

-23.53%-21K

-25.00%-20K

-26.67%-19K

-28.57%-18K

Total non current assets

--0

-57.14%3K

-50.00%4K

-44.44%5K

-40.00%6K

-36.36%7K

Total assets

3.15%44.83M

14.18%51.84M

10.12%53.95M

271.99%54.19M

142.83%43.47M

121.65%45.4M

87.87%48.99M

-37.22%14.57M

Liabilities

Current liabilities

Payables

-72.71%634K

-18.61%2.06M

55.56%2.15M

29.50%1.9M

23.17%2.32M

60.61%2.54M

-12.63%1.38M

2.37%1.47M

-accounts payable

-72.71%634K

-7.07%2.06M

101.40%2.15M

28.75%1.89M

23.17%2.32M

40.66%2.22M

-32.51%1.07M

2.37%1.47M

-Total tax payable

----

--0

--11K

--0

--315K

----

Current accrued expenses

54.49%3.49M

125.53%3.65M

32.58%1.82M

15.70%1.42M

59.31%2.26M

14.02%1.62M

-21.00%1.37M

1.58%1.22M

Other current liabilities

--74K

--93K

----

Current liabilities

-27.13%4.2M

39.31%5.79M

46.82%4.04M

45.26%3.91M

74.36%5.76M

29.29%4.15M

-28.59%2.75M

2.01%2.69M

Non current liabilities

Derivative product liabilities

----

--0

----

--0

Total non current liabilities

--0

Total liabilities

-27.13%4.2M

39.31%5.79M

46.82%4.04M

45.26%3.91M

74.36%5.76M

29.29%4.15M

-28.59%2.75M

2.01%2.69M

Shareholders'equity

Share capital

50.00%3K

0.00%2K

-common stock

50.00%3K

0.00%2K

-Preferred stock

--0

Retained earnings

-17.15%-96.34M

-14.63%-88.57M

-13.97%-81.47M

27.27%-76.67M

18.49%-82.23M

19.48%-77.27M

20.02%-71.48M

-26.93%-105.42M

Paid-in capital

14.20%136.97M

13.59%134.63M

11.60%131.37M

8.23%126.95M

3.85%119.93M

4.67%118.52M

5.49%117.72M

13.20%117.3M

Total stockholders'equity

7.78%40.64M

11.65%46.06M

7.93%49.91M

323.36%50.28M

158.34%37.7M

138.83%41.25M

108.08%46.24M

-42.25%11.88M

Total equity

7.78%40.64M

11.65%46.06M

7.93%49.91M

323.36%50.28M

158.34%37.7M

138.83%41.25M

108.08%46.24M

-42.25%11.88M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	3.54%41.41M	20.91%47.17M	18.35%50.52M	18.35%50.52M	203.53%42.36M	133.22%40M	101.28%39.01M	72.44%42.68M	72.44%42.68M	-38.34%13.96M
-Cash and cash equivalents	3.58%41.41M	20.96%47.16M	18.45%50.5M	18.45%50.5M	205.67%42.35M	134.81%39.98M	102.58%38.99M	73.78%42.63M	73.78%42.63M	-37.73%13.86M
-Short-term investments	-77.27%5K	-77.27%5K	-69.39%15K	-69.39%15K	-89.11%11K	-82.54%22K	-83.70%22K	-77.63%49K	-77.63%49K	-73.63%101K
Receivables	-15.53%2.31M	-41.18%3.12M	-51.90%2.33M	-51.90%2.33M	--11.34M	--2.73M	--5.3M	--4.85M	--4.85M	----
-Accounts receivable	905.93%1.36M	-32.11%1.92M	-28.66%926K	-28.66%926K	--10.13M	--135K	--2.83M	--1.3M	--1.3M	----
-Other receivables	-63.47%948K	-51.60%1.19M	-60.39%1.41M	-60.39%1.41M	--1.21M	--2.6M	--2.47M	--3.55M	--3.55M	----
Prepaid assets	49.49%1.03M	45.64%1.47M	-27.39%997K	-27.39%997K	-20.40%433K	-3.10%687K	-4.90%1.01M	10.46%1.37M	10.46%1.37M	5.84%544K
Other current assets	93.33%87K	14.10%89K	27.50%102K	27.50%102K	-16.39%51K	45.16%45K	136.36%78K	12.68%80K	12.68%80K	32.61%61K
Total current assets	3.16%44.83M	14.20%51.84M	10.13%53.95M	10.13%53.95M	272.14%54.19M	142.92%43.46M	121.72%45.4M	87.92%48.99M	87.92%48.99M	-37.22%14.56M
Non current assets
Net PPE	--0	--0	--0	--0	-57.14%3K	-50.00%4K	-44.44%5K	-40.00%6K	-40.00%6K	-36.36%7K
-Gross PPE	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K	0.00%25K
-Accumulated depreciation	-19.05%-25K	-25.00%-25K	-31.58%-25K	-31.58%-25K	-22.22%-22K	-23.53%-21K	-25.00%-20K	-26.67%-19K	-26.67%-19K	-28.57%-18K
Total non current assets	--0	--0	--0	--0	-57.14%3K	-50.00%4K	-44.44%5K	-40.00%6K	-40.00%6K	-36.36%7K
Total assets	3.15%44.83M	14.18%51.84M	10.12%53.95M	10.12%53.95M	271.99%54.19M	142.83%43.47M	121.65%45.4M	87.87%48.99M	87.87%48.99M	-37.22%14.57M
Liabilities
Current liabilities
Payables	-72.71%634K	-18.61%2.06M	55.56%2.15M	55.56%2.15M	29.50%1.9M	23.17%2.32M	60.61%2.54M	-12.63%1.38M	-12.63%1.38M	2.37%1.47M
-accounts payable	-72.71%634K	-7.07%2.06M	101.40%2.15M	101.40%2.15M	28.75%1.89M	23.17%2.32M	40.66%2.22M	-32.51%1.07M	-32.51%1.07M	2.37%1.47M
-Total tax payable	----	----	--0	--0	--11K	--0	--315K	--315K	--315K	----
Current accrued expenses	54.49%3.49M	125.53%3.65M	32.58%1.82M	32.58%1.82M	15.70%1.42M	59.31%2.26M	14.02%1.62M	-21.00%1.37M	-21.00%1.37M	1.58%1.22M
Other current liabilities	--74K	--74K	--74K	--74K	--93K	----	----	----	----	----
Current liabilities	-27.13%4.2M	39.31%5.79M	46.82%4.04M	46.82%4.04M	45.26%3.91M	74.36%5.76M	29.29%4.15M	-28.59%2.75M	-28.59%2.75M	2.01%2.69M
Non current liabilities
Derivative product liabilities	----	----	----	----	----	----	--0	----	----	--0
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	-27.13%4.2M	39.31%5.79M	46.82%4.04M	46.82%4.04M	45.26%3.91M	74.36%5.76M	29.29%4.15M	-28.59%2.75M	-28.59%2.75M	2.01%2.69M
Shareholders'equity
Share capital	50.00%3K	50.00%3K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K
-common stock	50.00%3K	50.00%3K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K	0.00%2K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-17.15%-96.34M	-14.63%-88.57M	-13.97%-81.47M	-13.97%-81.47M	27.27%-76.67M	18.49%-82.23M	19.48%-77.27M	20.02%-71.48M	20.02%-71.48M	-26.93%-105.42M
Paid-in capital	14.20%136.97M	13.59%134.63M	11.60%131.37M	11.60%131.37M	8.23%126.95M	3.85%119.93M	4.67%118.52M	5.49%117.72M	5.49%117.72M	13.20%117.3M
Total stockholders'equity	7.78%40.64M	11.65%46.06M	7.93%49.91M	7.93%49.91M	323.36%50.28M	158.34%37.7M	138.83%41.25M	108.08%46.24M	108.08%46.24M	-42.25%11.88M
Total equity	7.78%40.64M	11.65%46.06M	7.93%49.91M	7.93%49.91M	323.36%50.28M	158.34%37.7M	138.83%41.25M	108.08%46.24M	108.08%46.24M	-42.25%11.88M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall